Dear Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties : As we prepare to end 2025, we would like to provide you with this open letter summarizing our ...

Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...

The settlement ends a 2023 lawsuit alleging pharmaceutical companies manipulated ADHD medication quality tests.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...

The founder and a former top doctor at Done Global were convicted by a San Francisco jury of conspiring to distribute Adderall and other stimulants, in the first federal prosecution of alleged illegal ...

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

In two newly published studies, researchers at the Department of Ethology, Eötvös Loránd University (Hungary) investigated ...

Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...

Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...

Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to ...

Jury convicts Done Global founder Ruthia He and former top doctor David Brody in a federal case alleging illegal Adderall distribution through the telehealth platform.